Use of emergency contraception is increasing in the United States
August 1st 2011Analysis of data from the 2006-2008 National Survey of Family Growth reveals that use of emergency contraception in the US has more than doubled since 2002, from 4.2% to 9.7%, but remains highly dependent on whether physicians provide counseling about EC.
Did physician's failure to communicate biopsy results lead to patient's death?
August 1st 2011A Virginia woman went to her gynecologist for an annual physical. The pap smear revealed human papillomavirus and abnormal cells. A cone biopsy was performed and the pathology report from the biopsy revealed adenoid cystic carcinoma. However, the gynecologist did not tell the patient about the cervical cancer; instead she was told to undergo a hysterectomy.
Another disappointment for ovarian cancer screening
August 1st 2011Those who had hoped that the combination of routine screening with cancer antigen 125 (CA-125) and pelvic ultrasound would promote an earlier diagnosis and improved survival for women with ovarian cancer were dealt a harsh blow when the PLCO trail results were reported.
Hormone Replacement and Menopause: What are the Issues?
July 29th 2011Symptoms related to menopause, including insomnia, nervousness, melancholia, vertigo, weakness, fatigue, hot flashes, vaginal dryness, and urinary incontinence, denote a decline in a woman's quality of life. Further, the symptoms a woman may experience vary according to age.
Drospirenone/Ethinyl Estradiol (Yasmin®): New Oral Contraceptive Promises Improved Tolerance
July 29th 2011With a number of clinical studies now completed, the launch of drospirenone/ethinyl estradiol (Yasmin®) in the United States and Europe is expected in the near future. An international panel of physicians involved with the development of drospirenone/ethinyl estradiol recently described the potential benefits of the new oral contraceptive (OC) to clinicians attending an industry-sponsored symposium held during the XVI FIGO World Congress of Gynecology and Obstetrics.
The News on Hormone Replacement Therapy (HRT)
July 29th 2011There has been an explosion of hormone replacement therapy research over the past few years. The task of wading through the data to determine what is best for a particular patient, however, can be daunting at best and confusing at worst, said Dr. Karen Carlson, Massachusetts General Hospital, Boston, to delegates at the Pri-Med East in Boston.
Tailoring HRT to Your Patients: An Expert Roundtable Discussion on the Issue
The topic of hormone replacement therapy (HRT) continues to emerge as a central theme that we, as clinicians to female patients, address every day. We recognize that the public is much more aware of and interested in HRT now than was the case a decade ago.